PL2033635T3 - Zastosowanie kwasu fenylomasłowego lub jego soli do leczenia świądu - Google Patents
Zastosowanie kwasu fenylomasłowego lub jego soli do leczenia świąduInfo
- Publication number
- PL2033635T3 PL2033635T3 PL07115426T PL07115426T PL2033635T3 PL 2033635 T3 PL2033635 T3 PL 2033635T3 PL 07115426 T PL07115426 T PL 07115426T PL 07115426 T PL07115426 T PL 07115426T PL 2033635 T3 PL2033635 T3 PL 2033635T3
- Authority
- PL
- Poland
- Prior art keywords
- pruritus
- salt
- phenylbutyric acid
- treat pruritus
- mucosa
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07115426A EP2033635B1 (en) | 2007-08-31 | 2007-08-31 | Use of phenylbutyric acid or salts thereof for treating pruritus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2033635T3 true PL2033635T3 (pl) | 2012-01-31 |
Family
ID=38969500
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL07115426T PL2033635T3 (pl) | 2007-08-31 | 2007-08-31 | Zastosowanie kwasu fenylomasłowego lub jego soli do leczenia świądu |
Country Status (5)
| Country | Link |
|---|---|
| EP (2) | EP2033635B1 (pl) |
| AT (1) | ATE522208T1 (pl) |
| ES (1) | ES2371671T3 (pl) |
| PL (1) | PL2033635T3 (pl) |
| PT (1) | PT2033635E (pl) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5468015B2 (ja) | 2008-01-08 | 2014-04-09 | アクセリア ファーマシューティカルズ | 抗菌ペプチド系に対する作動薬 |
| WO2012131069A1 (en) * | 2011-03-31 | 2012-10-04 | Proponent Biotech Gmbh | Short chain fatty acids and their derivatives for use in treatment immunogenic disorders |
| CA2886270C (en) | 2012-10-03 | 2020-04-07 | Proponent Biotech Gmbh | Esters of short chains fatty acids for use in the treatment of immunogenic disorders |
| US11065217B2 (en) | 2017-01-27 | 2021-07-20 | Temple University—Of the Commonwealth System of Higher Education | Use of short chain fatty acids for the treatment and prevention of diseases and disorders |
| JP7136807B2 (ja) | 2017-04-17 | 2022-09-13 | ザ・ユニバーシティ・オブ・シカゴ | ヒトの健康及び疾患の治療用途向けの短鎖脂肪酸の腸への送達用ポリマー材料 |
| CN109589306A (zh) * | 2017-09-30 | 2019-04-09 | 上海交通大学医学院附属第九人民医院 | 脂质体在制备用于清除蛋白结合毒素的药物制剂中的用途 |
| KR102059027B1 (ko) * | 2018-01-12 | 2019-12-24 | 주식회사 비엔에이치리서치 | Hdac6 억제제를 유효성분으로 포함하는 가려움증 예방 또는 치료용 약제학적 조성물 |
| DE102018123014A1 (de) * | 2018-09-19 | 2020-03-19 | Flexopharm Brain Gmbh & Co. Kg | Mittel zur Verwendung bei der Behandlung von Patienten mit systemischen Entzündungserscheinungen und oxidativem Stress bei terminaler Niereninsuffizienz |
| CN109758444B (zh) * | 2019-03-27 | 2021-08-24 | 中国农业科学院特产研究所 | 2-甲基取代脂肪酸在抗氧化方面的应用 |
| WO2024117173A1 (ja) * | 2022-11-30 | 2024-06-06 | 花王株式会社 | 痒みの予防又は改善剤 |
| EP4628078A1 (en) | 2022-11-30 | 2025-10-08 | Kao Corporation | Agent for preventing or ameliorating itch |
| WO2025217435A1 (en) * | 2024-04-12 | 2025-10-16 | Aardvark Therapeutics Inc. | Pharmaceutical formulations containing phenylbutyrate and methods thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4207241A (en) * | 1967-01-13 | 1980-06-10 | Syntex Corporation | 2-Naphthyl acetic acid derivatives and compositions and methods thereof |
| EP1656935A1 (en) * | 2004-11-12 | 2006-05-17 | Cognis IP Management GmbH | Use of physiologically active fatty acids for the treatment of pruritus |
| GB0617191D0 (en) * | 2006-08-31 | 2006-10-11 | York Pharma Plc | Improvements in pharmaceutical compositions |
-
2007
- 2007-08-31 AT AT07115426T patent/ATE522208T1/de not_active IP Right Cessation
- 2007-08-31 PL PL07115426T patent/PL2033635T3/pl unknown
- 2007-08-31 EP EP07115426A patent/EP2033635B1/en not_active Not-in-force
- 2007-08-31 ES ES07115426T patent/ES2371671T3/es active Active
- 2007-08-31 PT PT07115426T patent/PT2033635E/pt unknown
- 2007-08-31 EP EP08161580A patent/EP2030616A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP2033635A1 (en) | 2009-03-11 |
| EP2033635B1 (en) | 2011-08-31 |
| PT2033635E (pt) | 2011-12-15 |
| EP2030616A1 (en) | 2009-03-04 |
| ES2371671T3 (es) | 2012-01-09 |
| ATE522208T1 (de) | 2011-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2033635T3 (pl) | Zastosowanie kwasu fenylomasłowego lub jego soli do leczenia świądu | |
| WO2009062118A3 (en) | Modulation of protein trafficking | |
| BR112013029246A2 (pt) | 4-amino-5-flúor-3-[6- (4-metilpiperazin- 1 - il) - 1h - benzimidazol - 2 - il] - 1h - quinolin-2-ona para uso no tratamento de carcinoma adenoide cístico | |
| SMT201300095B (it) | Uso dell'estere etilico dell'acido eicosapentaenoico per trattare l'ipertrigliceridemia | |
| HK1201065A1 (en) | Novel quinoxaline inhibitors of pi3k | |
| BR112015029491A2 (pt) | derivados de imidazopirrolidinona e seu uso no tratamento de doença | |
| CO6290687A2 (es) | Inhibidores de cinasa pim y metodos para su uso | |
| MX394763B (es) | Metodos para reducir riesgo de evento cardiovascular en sujeto con terapia con estatina | |
| AR090349A1 (es) | Terapia de combinacion para trastornos proliferativos, kit y uso | |
| BR112015015477A2 (pt) | derivados de 2,3-di-hidro-isoindol-1-ona e métodos de uso dos mesmos como inibidores de btk | |
| WO2012050831A3 (en) | Combination treatment for dermatological conditions | |
| WO2016085939A3 (en) | Compounds and methods of treating ocular disorders | |
| MX350666B (es) | Composiciones y sus usos para tratar hiperuricemia y trastornos metabolicos asociados con hiperuricemia. | |
| WO2012002687A3 (en) | Methods for treating bipolar disorder | |
| BR112015019369A2 (pt) | derivados de ácido bisfenil butanóico substituídos como inibidores de nep (endopeptidase neutra) | |
| BR112013007343A2 (pt) | métodos para tratar eritema associado com rosácea e para tratar telangiectasia associada com rosácea, e, composição tópica | |
| AR086444A1 (es) | Composiciones farmaceuticas y metodos para tratar el cancer | |
| BR112014010729A2 (pt) | métodos para tratamento de ataques de gota | |
| WO2012135812A3 (en) | Treatment for dermatological pathologies | |
| WO2013087654A3 (en) | Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulation | |
| BR112014002885A2 (pt) | uso de composto orgânico para o tratamento da síndrome de noonan | |
| BRPI0703970A2 (pt) | tratamento de pacientes psiquiátricos com função hepática reduzida com paliperidona | |
| UA112418C2 (uk) | Терапевтичний болезаспокійливий засіб | |
| BR112015001627A2 (pt) | composição farmacêutica, respectivos usos e método para diminuir a frequência de micção | |
| WO2014144836A3 (en) | Carbamate derivatives of lactam based n-acylethanolamine acid amidase (naaa) inhibitors |